To better understand the significance of these two genes (PARP6 and PARP10)—in the prognosis of AML patients, we generated Kaplan-Meier survival curves for the overall survival (OS) and event-free survival (EFS) of patients with high and low expression of these genes (cutoff: median expression). The gene discussed is PARP10; the disease is acute myeloid leukemia.